<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Diagnostic staging laparoscopy for digestive system cancers
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Diagnostic staging laparoscopy for digestive system cancers
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Diagnostic staging laparoscopy for digestive system cancers
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeffrey Marks, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stanley W Ashley, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 16, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1757598013">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic staging laparoscopy (DSL) is performed to determine the feasibility of the proposed curative cancer operation. DSL complements the preoperative assessment of radiographic imaging, which has limitations for identifying regional extension of the primary tumor and/or metastatic disease, such as peritoneal involvement [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
         The general principles and approach for performing a DSL for patients with a digestive malignancy are reviewed here. Laparoscopic assessment and/or resection of other malignant and benign diseases are discussed in separate topics.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/128278.html" rel="external">
          "Minimally invasive esophagectomy"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/109436.html" rel="external">
          "Laparoscopic gastrectomy for cancer"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/127000.html" rel="external">
          "Minimally invasive pancreatectomy (MIP)"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/109268.html" rel="external">
          "Minimally invasive liver resection (MILR)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7185349">
         <span class="h1">
          INDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goal of diagnostic staging laparoscopy (DSL) for primary digestive malignancies is to identify and/or disprove the presence of local, regional, and/or metastatic disease. DSL aids in identifying extra-organ disease that would preclude an attempt at an intended curative resection.
        </p>
        <p>
         Indications for DSL include [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assessment for resectability with curative intent of the following digestive cancers:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Esophageal cancer at the gastroesophageal junction or advanced (&gt;T1) gastric cancer (routinely) (see
         <a class="local">
          'Esophagogastric junction and gastric cancer'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pancreatic cancer located in the body or tail of the pancreas (routinely) (see
         <a class="local">
          'Pancreatic cancer'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Biliary tract cancer located in the proximal bile duct (intrahepatic or hilar cholangiocarcinoma, both selectively) or gallbladder (routinely) (see
         <a class="local">
          'Biliary tract cancer'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Colorectal liver metastasis (selectively)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Staging prior to administration of neoadjuvant chemotherapy or radiation therapy [
         <a href="#rid3">
          3
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assessment of equivocal magnetic resonance imaging (MRI), computed tomography (CT) scan, or positron emission tomography (PET) scan findings for primary, regional, or distant disease
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assessment of inconclusive histology following radiographic-guided fine needle aspiration of suspicious sites of disease
        </p>
        <p>
        </p>
        <p>
         For certain conditions, selective rather than routine use of DSL is warranted. DSL is cost effective if unresectable disease is identified and the patient is spared a laparotomy [
         <a href="#rid1">
          1
         </a>
         ]. However, DSL performed routinely increases the overall cost of the operative procedure. Patient selection is based on primary tumor site and is discussed below. (See
         <a class="local">
          'Diagnostic yield for specific digestive system cancers'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4971658">
         <span class="h1">
          CONTRAINDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic staging laparoscopy (DSL) is not a debulking procedure and should not be used for that purpose. It is not performed unless the treatment plan will be altered. Other contraindications include inability to tolerate laparoscopy and previously confirmed metastatic or unresectable disease [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         DSL is not recommended for proximal or midesophageal cancer, periampullary cancer/distal bile duct cancer, or hepatocellular carcinoma. The yield of DSL in these patients is not sufficiently high enough to justify the procedure. (See
         <a class="local">
          'Diagnostic yield for specific digestive system cancers'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4971261">
         <span class="h1">
          SURGICAL APPROACH
         </span>
         <span class="headingEndMark">
          —
         </span>
         This section reviews the basic surgical principles for performing a diagnostic staging laparoscopy (DSL).
        </p>
        <p class="headingAnchor" id="H4971269">
         <span class="h2">
          Incision placement
         </span>
         <span class="headingEndMark">
          —
         </span>
         The access point for the initial trocar placement should be remote from prior surgical incisions or suspected metastatic disease. Open techniques, Veress needle insufflation, and/or optical ports can be utilized at the discretion of the surgeon. An overview of the techniques for laparoscopic surgery is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/15103.html" rel="external">
          "Abdominal access techniques used in laparoscopic surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4971277">
         <span class="h2">
          Staging procedure
         </span>
        </p>
        <p class="headingAnchor" id="H91039794">
         <span class="h3">
          One- versus two-stage approach
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are two approaches to utilizing DSL. The first is to perform DSL as the sole intended procedure. The advantage of this approach includes identifying patients who may be more appropriately treated with chemotherapy or radiation therapy as the first cancer treatment. The disadvantage is that a second procedure will be required for the definitive cancer operation.
        </p>
        <p>
         The second approach involves performing DSL first, in the same setting where the definitive cancer operation will be performed if no unresectable and/or distant disease is identified. The advantage of this approach includes there being only one operative setting with one anesthetic administration. The disadvantages include the possible uncertainty of a frozen section report on a biopsy, need for final pathology to confirm a suspicious finding, and operating room time scheduling.
        </p>
        <p>
         A two-stage approach is common for esophagogastric junction (EGJ) cancer and gastric cancer, while a one-stage approach is typically used for hepatopancreatobiliary cancers [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4971299">
         <span class="h3">
          Exploratory principles
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laparoscopic exploration should be performed in an orderly fashion, evaluating for distant, regional, and local disease as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         After obtaining access into the peritoneal cavity, a generalized exploration of the peritoneal surfaces of the abdominal cavity is performed. An angled 30° or 45° laparoscope will aid in evaluation of surfaces in the pelvis, colic gutters, and the initial survey of the surface of the liver. (See
         <a class="medical medical_review" href="/z/d/html/4874.html" rel="external">
          "Instruments and devices used in laparoscopic surgery"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14953.html" rel="external">
          "Imaging studies after bariatric surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A thorough assessment of the local and regional sites should be performed next. For example, the gastrocolic ligament is divided in order to obtain entry into the lesser sac for evaluation of primary pancreatic and gastric malignancies. Abnormal lymphadenopathy should be adequately sampled via the laparoscope. A single suspicious lymph node should be resected in its entirety if technically possible.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Finally, a complete evaluation of the liver surface is performed using a combination of altered patient positioning and offsetting the angled laparoscope. Intraoperative laparoscopic ultrasound of the liver can be performed expeditiously to aid in identification of metastatic disease (see
         <a class="local">
          'Laparoscopic ultrasound'
         </a>
         below). Alteration in patient positioning and port placement will assist with the ultrasound evaluation. (See
         <a class="medical medical_review" href="/z/d/html/4874.html" rel="external">
          "Instruments and devices used in laparoscopic surgery"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14953.html" rel="external">
          "Imaging studies after bariatric surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For any patient with a suspicion for metastatic or otherwise unresectable disease that cannot be confirmed with laparoscopy, conversion to an open laparotomy should be performed.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4274098666">
         <span class="h3">
          Peritoneal washing
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with ascites, fluid is sampled for cytologic analysis. Peritoneal washing in patients with digestive malignancy without ascites is typically not performed, except for patients with EGJ cancers or gastric cancers [
         <a href="#rid4">
          4,5
         </a>
         ]. Peritoneal washing is performed before any biopsy is taken. (See
         <a class="local">
          'Esophagogastric junction and gastric cancer'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4971337">
         <span class="h3">
          Biopsies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Biopsies are performed on suspicious lesions. If DSL is performed immediately before the planned definitive resection, a frozen section is obtained. Otherwise, the biopsy tissue is submitted for a final histologic evaluation.
        </p>
        <p>
         Minimizing the use of electrocautery at the time of the biopsy will minimize thermal artifact effect. Laparoscopic graspers, cup biopsy forceps, and/or scissors can be used to aid in sampling of tissue. If metastatic disease is confirmed on the frozen section and no palliative procedure is indicated, the operation is concluded.
        </p>
        <p>
         If the frozen section results are uncertain, ideally, histologic confirmation with permanent hematoxylin and eosin staining of tissue or other special stains will be obtained, as needed, before proceeding with a definitive operative procedure. For those patients with inconclusive results from laparoscopic biopsies, several options are available, including a second pathologist evaluation, repeat laparoscopy, or proceeding to an open laparotomy with the intent for treatment if no metastatic disease is subsequently identified.
        </p>
        <p class="headingAnchor" id="H1167526559">
         <span class="h3">
          Laparoscopic ultrasound
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laparoscopic ultrasound (LUS) serves as an adjunct to preoperative radiographic imaging studies and DSL for staging of select cancers. The utility of LUS may be in identifying patients who are not candidates for a primary resection, because of misdiagnosis or misinterpretation of radiographic imaging.
        </p>
        <p>
         We suggest performing LUS with DSL for planning a resection of primary and metastatic liver cancer. LUS can correctly identify unresectable disease and prevent unnecessary laparotomy in about one-third of patients with both primary and secondary hepatic malignancies [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="local">
          'Liver cancer'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4971366">
         <span class="h2">
          Risks and complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are few additional risks associated with DSL other than the general risks of laparoscopy. (See
         <a class="medical medical_review" href="/z/d/html/88846.html" rel="external">
          "Complications of laparoscopic surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H922054">
         <span class="h3">
          Morbidity and mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         The overall morbidity and mortality rates of DSL for patients with primary digestive cancers are low in comparison with an open laparotomy. The morbidity associated with DSL for esophageal, gastric, and pancreatic cancer patients ranges from 0 to 2.5 percent [
         <a href="#rid7">
          7,8
         </a>
         ], while no mortality was related to DSL. In comparison, the operative morbidity and mortality rates of a diagnostic laparotomy for patients with unresectable gastric cancer range from 13 to 23 percent and 10 to 21 percent, respectively [
         <a href="#rid9">
          9-11
         </a>
         ]. Therefore, DSL can be performed safely to identify patients who are candidates for a primary resection and permit the rest to recover quickly before the initiation of systemic therapy [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4971374">
         <span class="h3">
          Port site tumor implantation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Port site tumor implantation following laparoscopic intervention for upper gastrointestinal malignancy is less than 1 percent, with a median time to occurrence of eight months [
         <a href="#rid14">
          14
         </a>
         ]. In a review of 1650 procedures, almost all patients who developed a port site recurrence also had developed a local recurrence and/or distant disease [
         <a href="#rid15">
          15
         </a>
         ]. The contemporary risk of port site implantation is comparable to that of a laparotomy incision as the site of tumor implantation. (See
         <a class="medical medical_review" href="/z/d/html/88846.html" rel="external">
          "Complications of laparoscopic surgery", section on 'Trocar site metastasis'
         </a>
         .)
        </p>
        <p>
         Approaches suggested to reduce the risk of port site implantation include [
         <a href="#rid16">
          16
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Place trocars perpendicular to the peritoneum
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prevent carbon dioxide leakage around trocars
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Minimize handling of tumor tissue
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protect extraction sites
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bag specimens intra-abdominally to avoid spillage
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Remove entire lesion rather than an excisional biopsy if possible
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Drain the peritoneal cavity before deflating
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Deflate the abdomen with trocars in place
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Close the fascia of the trocar port site while avoiding liquid spillage into the wound
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7185906">
         <span class="h1">
          DIAGNOSTIC YIELD FOR SPECIFIC DIGESTIVE SYSTEM CANCERS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Conventional imaging studies (eg, MRI, CT scan) often understage the intra-abdominal extent of cancer [
         <a href="#rid1">
          1
         </a>
         ]. In the setting of a negative high-quality radiographic preoperative evaluation, diagnostic staging laparoscopy (DSL) performed prior to a planned major resection may spare the patient an unnecessary laparotomy and decrease the time to chemotherapy or radiation therapy.
        </p>
        <p>
         The accuracy of DSL is defined as the number of unresectable patients detected by DSL divided by the total number of unresectable cases [
         <a href="#rid17">
          17
         </a>
         ]. Yield is defined as the number of unresectable patients detected by DSL divided by the total number of patients undergoing DSL [
         <a href="#rid17">
          17
         </a>
         ]. The yield and/or accuracy of DSL for primary digestive cancers are illustrated by the following disease-specific examples.
        </p>
        <p class="headingAnchor" id="H7186030">
         <span class="h2">
          Esophagogastric junction and gastric cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with esophagogastric junction (EGJ) cancer of any stage or gastric cancer that is beyond T1 stage, we suggest routine DSL with peritoneal washing before open resection or neoadjuvant chemotherapy. Our suggestion is consistent with guidelines from the National Comprehensive Cancer Network (NCCN) [
         <a href="#rid18">
          18
         </a>
         ] and the European Organisation for Research and Treatment of Cancer [
         <a href="#rid19">
          19
         </a>
         ]. Despite such endorsements, DSL is underutilized for EGJ and gastric cancers [
         <a href="#rid20">
          20,21
         </a>
         ].
        </p>
        <p>
         Patients with adenocarcinoma arising from the intra-abdominal segment (ie, Siewert type II or III)  (
         <a class="graphic graphic_figure graphicRef101001" href="/z/d/graphic/101001.html" rel="external">
          figure 1
         </a>
         ) and those with locally advanced gastric cancer are particularly prone to developing intraperitoneal metastasis. Intraperitoneal metastases are notoriously difficult to diagnose noninvasively by either CT or positron emission tomography (PET) [
         <a href="#rid22">
          22,23
         </a>
         ]. In a prospective study, DSL outperformed PET scans in detecting occult peritoneal metastasis which changed treatment intent (19 versus 3 percent) [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Laparoscopy, while more invasive than CT or endoscopic ultrasound (EUS), has the advantage of directly visualizing the liver surface, peritoneum, and local lymph nodes. A substantial proportion of patients who have disease that is beyond T1 stage on EUS will be found to have peritoneal metastases despite having a negative CT or MRI scan. Peritoneal disease is detected in 43 to 52 percent of patients from the Japanese series and 7.8 to 40 percent of patients in studies from other countries [
         <a href="#rid25">
          25,26
         </a>
         ]. In multiple cohort studies, DSL for EGJ and gastric cancers demonstrated a high accuracy of 93 to 95 percent [
         <a href="#rid8">
          8,27
         </a>
         ].
        </p>
        <p>
         Another advantage to laparoscopy is the opportunity to perform peritoneal washing in patients who have no visible evidence of peritoneal spread. In most series, a positive peritoneal cytology is a poor prognostic sign, even in the absence of overt peritoneal dissemination, and predicts for early peritoneal relapse and dismal prognosis [
         <a href="#rid28">
          28,29
         </a>
         ]. Adding peritoneal washing to DSL further enhances its yield in detecting occult metastatic diseases [
         <a href="#rid4">
          4,30
         </a>
         ]. After completion of neoadjuvant therapy for cytologic but not macroscopic metastatic disease, we repeat DSL before attempting any open resection [
         <a href="#rid25">
          25,31
         </a>
         ].
        </p>
        <p>
         We routinely obtain peritoneal washings during DSL in patients who lack visible peritoneal disease and refer patients with positive cytology in the absence of other evidence of metastatic disease for neoadjuvant approaches. To obtain washings, we generally infuse 200 cc of
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         and collect the aspirate using a Lukens trap at each site. We send washing samples separately from the right upper quadrant, left upper quadrant, and pelvis. Immunohistochemistry stains can be applied to cytologic specimens for better sensitivity to detect malignant cells. (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Neoadjuvant chemotherapy and chemoradiotherapy'
         </a>
         .)
        </p>
        <p>
         Risk factors associated with detecting peritoneal metastasis on DSL include T4 stage, N+ stage, poor differentiation, Borrmann type IV, high CA125, and large tumor diameter [
         <a href="#rid32">
          32
         </a>
         ]. When large tumors (T3 or T4) only are considered, the diagnostic accuracy increases. In those with advanced (T4) primary tumors or a linitis plastica appearance, performance of a diagnostic laparoscopy may alter management (typically by avoiding an unnecessary laparotomy) in up to one-half of patients [
         <a href="#rid33">
          33,34
         </a>
         ].
        </p>
        <p>
         Some experts suggest that all patients with EUS stage T3/T4 disease undergo staging laparoscopy, but not those with earlier-stage disease [
         <a href="#rid35">
          35
         </a>
         ]. However, we believe it can sometimes be difficult to differentiate T2 and T3 lesions on EUS, and up to 10 percent of patients with T2 disease may have peritoneal metastasis [
         <a href="#rid36">
          36
         </a>
         ]. Thus, our practice is to use preoperative staging laparoscopy for any medically fit patient who appears to have more than a T1 lesion on EUS, no histologic confirmation of stage IV disease, and who would not otherwise require a palliative gastrectomy because of symptoms. Diagnostic laparoscopy is especially important for patients who are being considered for neoadjuvant therapy trials [
         <a href="#rid3">
          3,37
         </a>
         ].
        </p>
        <p>
         DSL is not routinely indicated for patients with proximal or middle esophageal cancer. A review of 195 patients with esophageal cancer, including proximal, middle, middle and distal, and distal esophageal cancer locations, found that the DSL altered treatment plans in 29 patients (15 percent) [
         <a href="#rid38">
          38
         </a>
         ]. No patient with a proximal or middle esophageal cancer had unresectable or treatment-altering disease identified. However, 17 percent of patients with a distal esophageal cancer had regional or metastatic disease identified, which altered the initial treatment plan.
        </p>
        <p>
         Many patients with gastric cancer present with bleeding or obstruction and require, at the minimum, a palliative procedure. For those with obstructive symptoms only, endoscopic stenting in conjunction with DSL can be used to provide appropriate palliation and diagnosis and spare patients an unnecessary laparotomy, unless image-guided percutaneous biopsy can be performed in lieu of DSL to establish a cancer diagnosis. Alternatively, a DSL can be performed with a laparoscopic gastrojejunostomy as a surgical palliation [
         <a href="#rid39">
          39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2676.html" rel="external">
          "Enteral stents for the palliation of malignant gastroduodenal obstruction"
         </a>
         .)
        </p>
        <p>
         The diagnosis, staging, and accuracy of radiographic imaging are discussed elsewhere. Refer to individual topic reviews for treatment of gastric cancer based on the stage of disease. (See
         <a class="medical medical_review" href="/z/d/html/2513.html" rel="external">
          "Clinical features, diagnosis, and staging of gastric cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2502.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of esophageal cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2478.html" rel="external">
          "Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1757598027">
         <span class="h2">
          Pancreatic cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         For pancreatic cancer, we perform DSL selectively in those who have a large tumor (&gt;3 cm) or high tumor marker (eg, CA19-9 &gt;150 U/mL). However, the criteria of DSL for pancreatic and periampullary cancer are controversial. Other experts may reasonably choose to perform or omit DSL based on the location of the tumor.
        </p>
        <p>
         Pancreatic cancers are described by their location in the organ (ie, head, body, tail). Periampullary (peripancreatic) cancers include the ducts of the head and uncinate process of the pancreas, ampulla of Vater, distal common bile duct, and the duodenum. Many studies evaluating the yield of DSL have not differentiated pancreatic from nonpancreatic periampullary cancers [
         <a href="#rid2">
          2,40,41
         </a>
         ].
        </p>
        <p>
         Assessment of the regional extent of retroperitoneal disease by conventional radiographic imaging is limited. Meta-analyses found that 20 percent (range 14 to 38 percent) of patients with resectable diseases and 36 percent of those with locally advanced diseases could have avoided an open laparotomy if they had undergone a DSL following CT imaging [
         <a href="#rid42">
          42,43
         </a>
         ]. A 2023 study of over 1000 patients showed a positive DSL rate of 18 percent [
         <a href="#rid44">
          44
         </a>
         ]. Risk factors included age &lt;60, indeterminate extrapancreatic lesions on preoperative imaging, body/tail tumor location, larger tumor size, and elevated serum CA 19-9.
        </p>
        <p>
         However, DSL may not be beneficial for every patient with a suspected pancreatic or periampullary malignancy staged with increasingly higher-quality radiographic imaging [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consensus among experts advocates for performing DSL selectively prior to pancreatic resection, such as in patients with tumor ≥3 cm or with CA19-9 &gt;150 U/mL [
         <a href="#rid46">
          46,47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evidence suggests that patients with cancers of the body or tail of the pancreas are more likely to benefit from DSL than those with a pancreatic head cancer. DSL identified occult disease 2.6 to 5 times as frequently with cancers in the pancreatic body or tail compared with cancers in the pancreatic head [
         <a href="#rid48">
          48,49
         </a>
         ]. Current thinking is that tumors of the body and tail of the pancreas are asymptomatic for a longer period of time than cancers of the pancreatic head so that they are diagnosed at a later stage when peritoneal spread is more likely [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There appears to be little advantage of performing DSL for periampullary cancers [
         <a href="#rid51">
          51-57
         </a>
         ]. Unnecessary laparotomy was avoided in only 2.3 percent of patients with nonpancreatic periampullary cancer, compared with 35 percent for patients with cancer in the body and tail of the pancreas [
         <a href="#rid57">
          57
         </a>
         ]. The reasons for this finding are unclear.
        </p>
        <p>
        </p>
        <p>
         The diagnosis and staging of pancreatic cancer are discussed elsewhere. Refer to individual topic reviews for treatment of pancreatic cancer based on stage of disease. (See
         <a class="medical medical_review" href="/z/d/html/2501.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer"
         </a>
         .)
        </p>
        <p>
         The diagnosis and treatment of periampullary cancer are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/655.html" rel="external">
          "Ampullary carcinoma: Epidemiology, clinical manifestations, diagnosis and staging"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2506.html" rel="external">
          "Ampullary carcinoma: Treatment and prognosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1757598034">
         <span class="h2">
          Biliary tract cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Biliary tract cancers include cholangiocarcinoma and gallbladder cancer. We suggest routine DSL for patients with gallbladder cancer, selective DSL for patients with cholangiocarcinoma of the proximal bile duct (intrahepatic and hilar), but no DSL for those with distal biliary cancers.
        </p>
        <p class="headingAnchor" id="H2587648415">
         <span class="h3">
          Gallbladder cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         DSL prevents nontherapeutic laparotomy in 38 to 62 percent of gallbladder cancer patients [
         <a href="#rid58">
          58
         </a>
         ]. Simple DSL can detect unresectable disease in up to 23 percent of patients, and the yield is further increased by adding laparoscopic ultrasound and laparoscopic lymph node biopsy [
         <a href="#rid59">
          59
         </a>
         ]. Given the propensity for gallbladder cancer to spread to lymph nodes and peritoneal surfaces, experts recommend routine DSL for all patients suspected or proven to have gallbladder cancer prior to attempting open radical resection [
         <a href="#rid40">
          40,60-62
         </a>
         ].
        </p>
        <p>
         The diagnosis, staging, and treatment of biliary tract cancers, including cholangiocarcinoma and gallbladder cancer, are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2491.html" rel="external">
          "Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15097.html" rel="external">
          "Surgical management of gallbladder cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H508644100">
         <span class="h3">
          Cholangiocarcinoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cholangiocarcinoma can arise anywhere along the biliary tree, including intrahepatic, hilar, and distal cholangiocarcinoma.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with intrahepatic cholangiocarcinoma, DSL detects unresectable disease in 20 to 36 percent of those with radiographically resectable disease [
         <a href="#rid58">
          58,63,64
         </a>
         ]. Thus, expert consensus opinion recommends selective DSL in high-risk patients with elevated CA 19-9 levels or preoperative imaging demonstrating multicentric hepatic lesions, questionable vascular invasion, or extrahepatic metastasis [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with hilar cholangiocarcinoma, DSL detects unresectable disease in 24 percent (range 6 to 45 percent) of patients who are radiographically resectable [
         <a href="#rid63">
          63,66,67
         </a>
         ]. Local invasion of hilar structures is a main determinant of resectability in hilar cholangiocarcinoma, which is not usually identified during DSL. Thus, an expert consensus opinion recommends selective DSL in high-risk patients [
         <a href="#rid68">
          68
         </a>
         ]. Tumor size &gt;4.5 cm, bilateral portal vein or main portal vein tumor involvement, and suspected lymph node or extrahepatic metastases were identified as risk factors that predicted positive findings on DSL [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Distal cholangiocarcinoma is treated like periampullary cancer for which DSL is not performed. (See
         <a class="local">
          'Pancreatic cancer'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         The diagnosis, staging, and treatment of cholangiocarcinoma are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2500.html" rel="external">
          "Clinical manifestations and diagnosis of cholangiocarcinoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2524.html" rel="external">
          "Systemic therapy for advanced cholangiocarcinoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2467.html" rel="external">
          "Adjuvant and neoadjuvant therapy for localized cholangiocarcinoma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H37551011">
         <span class="h2">
          Liver cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest selective DSL with laparoscopic ultrasound in patients undergoing open resection for colorectal liver metastasis (CRLM), but no DSL for hepatocellular carcinoma (HCC).
        </p>
        <p class="headingAnchor" id="H602544447">
         <span class="h3">
          Colorectal liver metastasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although the overall yield of DSL for CRLM resection is low [
         <a href="#rid63">
          63
         </a>
         ], selected patients may benefit from it [
         <a href="#rid70">
          70
         </a>
         ]. DSL is more likely to detect unresectable disease in patients with a disease-free interval &lt;1 year, &gt;1 CRLM, CRLM &gt;5 cm, lymph node positive primary tumor, and carcinoembryonic antigen &gt;200 ng/mL [
         <a href="#rid71">
          71
         </a>
         ]. In patients who meet two or more of these criteria, more than a third were found to have unresectable disease on DSL [
         <a href="#rid72">
          72-74
         </a>
         ]. Thus, DSL should be used selectively before open CRLM resection in those at high risk for occult metastasis.
        </p>
        <p>
         The diagnosis, staging, and surgical management of CRLM are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2483.html" rel="external">
          "Potentially resectable colorectal cancer liver metastases: Integration of surgery and chemotherapy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/115954.html" rel="external">
          "Hepatic resection for colorectal cancer liver metastasis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H453291910">
         <span class="h3">
          Hepatocellular carcinoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite a reasonable early yield of 16 to 36 percent [
         <a href="#rid63">
          63,75
         </a>
         ], increasingly sophisticated imaging has rendered DSL unnecessary for HCC. In a contemporary study of 56 patients, the yield of DSL was only 7 percent [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
         The diagnosis, staging, and surgical management of HCC are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3597.html" rel="external">
          "Clinical features and diagnosis of hepatocellular carcinoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2476.html" rel="external">
          "Staging and prognostic factors in hepatocellular carcinoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2488.html" rel="external">
          "Surgical resection of hepatocellular carcinoma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1757598041">
         <span class="h2">
          Colon or rectal cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         DSL is used infrequently in patients with colon or rectal cancer, as resection is increasingly carried out laparoscopically or robotically, and removal of the primary lesion is necessary in most patients to control or avoid bleeding, obstruction, and/or perforation of the colon [
         <a href="#rid1">
          1
         </a>
         ]. DSL may be used selectively before open resection of CRLM. (See
         <a class="local">
          'Colorectal liver metastasis'
         </a>
         above.)
        </p>
        <p>
         The diagnosis, staging, and surgical management of colon cancer and rectal cancers are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2496.html" rel="external">
          "Clinical presentation, diagnosis, and staging of colorectal cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2507.html" rel="external">
          "Overview of the management of primary colon cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15311.html" rel="external">
          "Surgical treatment of rectal cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4119388624">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/139207.html" rel="external">
          "Society guideline links: Diagnostic laparoscopy"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/116783.html" rel="external">
          "Society guideline links: Laparoscopic and robotic surgery"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/111947.html" rel="external">
          "Society guideline links: Pancreatic cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H35659574">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Role of DSL
         </strong>
         – The role of diagnostic staging laparoscopy (DSL) prior to a planned definitive resection of a digestive cancer is to determine the feasibility of the proposed cancer operation. DSL is performed to identify any local, regional, and/or metastatic disease that would preclude an attempt at an intended curative surgical procedure. (See
         <a class="local">
          'Indications'
         </a>
         above and
         <a class="local">
          'Contraindications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          DSL procedure
         </strong>
         – The DSL procedure should be performed in an orderly fashion, carefully assessing for occult local, regional, and distant sites of disease. We perform a biopsy for suspicious lesions and cytology in the presence of ascites; peritoneal washing is added for esophagogastric junction (EGJ) and gastric cancer; laparoscopic ultrasound is added for primary to secondary liver tumors. (See
         <a class="local">
          'Staging procedure'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          DSL for esophageal or gastric cancer
         </strong>
         – (See
         <a class="local">
          'Esophagogastric junction and gastric cancer'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For EGJ cancer of any stage or gastric cancer that is beyond T1 stage, we routinely perform DSL with peritoneal washing before open resection or neoadjuvant chemotherapy.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We do not perform DSL for proximal or midesophageal tumors or early gastric cancer.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          DSL for pancreatic cancer
         </strong>
         – We perform DSL selectively in those who have a large pancreatic cancer (≥3 cm) or high tumor marker (eg, CA19-9 &gt;150 U/mL). However, the criteria of DSL for pancreatic and periampullary cancer are controversial. Other experts may reasonably choose to perform or omit DSL based on the location of the tumor. (See
         <a class="local">
          'Pancreatic cancer'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          DSL for biliary tract cancer
         </strong>
         – (See
         <a class="local">
          'Biliary tract cancer'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We routinely perform DSL for gallbladder cancer.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For intrahepatic or hilar cholangiocarcinoma, we perform DSL selectively for tumor &gt;4.5 cm, bilateral portal vein or main portal vein tumor involvement, and suspected lymph node or extrahepatic metastases.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We do not perform DSL for distal biliary cancers.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          DSL for liver cancer
         </strong>
         – (See
         <a class="local">
          'Liver cancer'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients undergoing open resection for colorectal liver metastasis (CRLM), we perform DSL with laparoscopic ultrasound selectively in patients who have a disease-free interval &lt;1 year, &gt;1 CRLM, CRLM &gt;5 cm, lymph node positive primary tumor, or carcinoembryonic antigen &gt;200 ng/mL.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We do not perform DSL for hepatocellular carcinoma (HCC).
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Guidelines for diagnostic laparoscopy. Reviewed and approved in April 2010. Available at: https://www.sages.org/publications/guidelines/guidelines-for-diagnostic-laparoscopy/ (Accessed on May 05, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen NA, Kingham TP. Minimally Invasive Staging Surgery for Cancer. Surg Oncol Clin N Am 2019; 28:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bintintan VV, Cordoş A, Chira R, et al. The Value of Staging Laparoscopy for Optimal Multidisciplinary Treatment in Patients with Gastric Cancer. Chirurgia (Bucur) 2018; 113:789.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munasinghe A, Kazi W, Taniere P, et al. The incremental benefit of two quadrant lavage for peritoneal cytology at staging laparoscopy for oesophagogastric adenocarcinoma. Surg Endosc 2013; 27:4049.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Andrade JP, Mezhir JJ. The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review. J Surg Oncol 2014; 110:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rethy A, Langø T, Mårvik R. Laparoscopic ultrasound for hepatocellular carcinoma and colorectal liver metastasis: an overview. Surg Laparosc Endosc Percutan Tech 2013; 23:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muntean V, Oniu T, Lungoci C, et al. Staging laparoscopy in digestive cancers. J Gastrointestin Liver Dis 2009; 18:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muntean V, Mihailov A, Iancu C, et al. Staging laparoscopy in gastric cancer. Accuracy and impact on therapy. J Gastrointestin Liver Dis 2009; 18:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Viste A, Haùgstvedt T, Eide GE, Søreide O. Postoperative complications and mortality after surgery for gastric cancer. Ann Surg 1988; 207:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irvin TT, Bridger JE. Gastric cancer: an audit of 122 consecutive cases and the results of R1 gastrectomy. Br J Surg 1988; 75:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valen B, Viste A, Haugstvedt T, et al. Treatment of stomach cancer, a national experience. Br J Surg 1988; 75:708.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beenen E, van Roest MH, Sieders E, et al. Staging laparoscopy in patients scheduled for pancreaticoduodenectomy minimizes hospitalization in the remaining life time when metastatic carcinoma is found. Eur J Surg Oncol 2014; 40:989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hashimoto D, Chikamoto A, Sakata K, et al. Staging laparoscopy leads to rapid induction of chemotherapy for unresectable pancreatobiliary cancers. Asian J Endosc Surg 2015; 8:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shoup M, Brennan MF, Karpeh MS, et al. Port site metastasis after diagnostic laparoscopy for upper gastrointestinal tract malignancies: an uncommon entity. Ann Surg Oncol 2002; 9:632.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziprin P, Ridgway PF, Peck DH, Darzi AW. The theories and realities of port-site metastases: a critical appraisal. J Am Coll Surg 2002; 195:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Curet MJ. Port site metastases. Am J Surg 2004; 187:705.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Connor S, Barron E, Wigmore SJ, et al. The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J Gastrointest Surg 2005; 9:476.
          </a>
         </li>
         <li class="breakAll">
          National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Esophageal and esophagogastric junction cancers. Version 1.2020 - March 18, 2020. Available at: https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf (Accessed on May 05, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lutz MP, Zalcberg JR, Ducreux M, et al. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. Eur J Cancer 2019; 112:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groh EM, Gupta S, Brown ZJ, et al. Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma. Ann Surg Oncol 2020; 27:1473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leder Macek AJ, Wang A, Turgeon MK, et al. Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis. J Surg Oncol 2022; 126:649.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanjeevaiah A, Park H, Fangman B, Porembka M. Gastric Cancer with Radiographically Occult Metastatic Disease: Biology, Challenges, and Diagnostic Approaches. Cancers (Basel) 2020; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li ZY, Tang L, Li ZM, et al. Four-Point Computed Tomography Scores for Evaluation of Occult Peritoneal Metastasis in Patients with Gastric Cancer: A Region-to-Region Comparison with Staging Laparoscopy. Ann Surg Oncol 2020; 27:1103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gertsen EC, Brenkman HJF, van Hillegersberg R, et al. 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC). JAMA Surg 2021; 156:e215340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fukagawa T. Role of staging laparoscopy for gastric cancer patients. Ann Gastroenterol Surg 2019; 3:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borgstein ABJ, van Berge Henegouwen MI, Lameris W, et al. Staging laparoscopy in gastric cancer surgery. A population-based cohort study in patients undergoing gastrectomy with curative intent. Eur J Surg Oncol 2021; 47:1441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borgstein ABJ, Keywani K, Eshuis WJ, et al. Staging laparoscopy in patients with advanced gastric cancer: A single center cohort study. Eur J Surg Oncol 2022; 48:362.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Convie L, Thompson RJ, Kennedy R, et al. The current role of staging laparoscopy in oesophagogastric cancer. Ann R Coll Surg Engl 2015; 97:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leake PA, Cardoso R, Seevaratnam R, et al. A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer. Gastric Cancer 2012; 15 Suppl 1:S27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yüksel C, Erşen O, Basceken SI, et al. The role of laparoscopic staging for the management of gastric cancer. Pol Przegl Chir 2021; 93:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thiels CA, Ikoma N, Fournier K, et al. Repeat staging laparoscopy for gastric cancer after preoperative therapy. J Surg Oncol 2018; 118:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guan G, Li Z, Wang Q, et al. Risk factors associated with peritoneal carcinomatosis of gastric cancer in staging laparoscopy: A systematic review and meta-analysis. Front Oncol 2022; 12:955181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leake PA, Cardoso R, Seevaratnam R, et al. A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer. Gastric Cancer 2012; 15 Suppl 1:S38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simon M, Mal F, Perniceni T, et al. Accuracy of staging laparoscopy in detecting peritoneal dissemination in patients with gastroesophageal adenocarcinoma. Dis Esophagus 2016; 29:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Power DG, Schattner MA, Gerdes H, et al. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg 2009; 208:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen CJ, Blumenthaler AN, Das P, et al. Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma. World J Surg Oncol 2020; 18:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Komori K, Kano K, Yamada T, et al. Usefulness of Surgical Staging of Gastric Cancer in Neoadjuvant Chemotherapy Candidates: A Single-center Retrospective Study. Anticancer Res 2022; 42:2719.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Graaf GW, Ayantunde AA, Parsons SL, et al. The role of staging laparoscopy in oesophagogastric cancers. Eur J Surg Oncol 2007; 33:988.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yasufuku I, Ohashi M, Makuuchi R, et al. High prevalence of peritoneal metastasis in gastric cancer presenting gastric outlet obstruction: A new candidate for consecutive diagnostic staging laparoscopy and laparoscopic gastrojejunostomy. Eur J Surg Oncol 2022; 48:1746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davidson JT 4th, Jin LX, Krasnick B, et al. Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions. J Surg Oncol 2019; 119:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paracha M, Van Orden K, Patts G, et al. Opportunity Lost? Diagnostic Laparoscopy in Patients with Pancreatic Cancer in the National Surgical Quality Improvement Program Database. World J Surg 2019; 43:937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen VB, Gurusamy KS, Takwoingi Y, et al. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev 2016; 7:CD009323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ta R, O'Connor DB, Sulistijo A, et al. The Role of Staging Laparoscopy in Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis. Dig Surg 2019; 36:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gudmundsdottir H, Yonkus JA, Alva-Ruiz R, et al. Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of More than 1,000 Consecutive Patients. J Am Coll Surg 2023; 237:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fong ZV, Alvino DML, Fernández-Del Castillo C, et al. Reappraisal of Staging Laparoscopy for Patients with Pancreatic Adenocarcinoma: A Contemporary Analysis of 1001 Patients. Ann Surg Oncol 2017; 24:3203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Callery MP, Chang KJ, Fishman EK, et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 2009; 16:1727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Rosa A, Cameron IC, Gomez D. Indications for staging laparoscopy in pancreatic cancer. HPB (Oxford) 2016; 18:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takadate T, Morikawa T, Ishida M, et al. Staging laparoscopy is mandatory for the treatment of pancreatic cancer to avoid missing radiologically negative metastases. Surg Today 2021; 51:686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Imamura T, Ohgi K, Okamura Y, et al. The clinical benefits of performing staging laparoscopy for pancreatic cancer treatment. Pancreatology 2022; 22:636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee M, Kwon W, Kim H, et al. The Role of Location of Tumor in the Prognosis of the Pancreatic Cancer. Cancers (Basel) 2020; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stefanidis D, Grove KD, Schwesinger WH, Thomas CR Jr. The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. Ann Oncol 2006; 17:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nieveen van Dijkum EJ, Romijn MG, Terwee CB, et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 2003; 237:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brooks AD, Mallis MJ, Brennan MF, Conlon KC. The value of laparoscopy in the management of ampullary, duodenal, and distal bile duct tumors. J Gastrointest Surg 2002; 6:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tilleman EH, Kuiken BW, Phoa SS, et al. Limitation of diagnostic laparoscopy for patients with a periampullary carcinoma. Eur J Surg Oncol 2004; 30:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vollmer CM, Drebin JA, Middleton WD, et al. Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies. Ann Surg 2002; 235:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           White R, Winston C, Gonen M, et al. Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. J Am Coll Surg 2008; 206:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barreiro CJ, Lillemoe KD, Koniaris LG, et al. Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit? J Gastrointest Surg 2002; 6:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goere D, Wagholikar GD, Pessaux P, et al. Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 2006; 20:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agarwal AK, Kalayarasan R, Javed A, et al. The role of staging laparoscopy in primary gall bladder cancer--an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer. Ann Surg 2013; 258:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aloia TA, Járufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford) 2015; 17:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hickman L, Contreras C. Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies. Surg Clin North Am 2019; 99:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Dooren M, de Savornin Lohman EAJ, Brekelmans E, et al. The diagnostic value of staging laparoscopy in gallbladder cancer: a nationwide cohort study. World J Surg Oncol 2023; 21:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Angelica M, Fong Y, Weber S, et al. The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol 2003; 10:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franken LC, Coelen RJS, Roos E, et al. Staging Laparoscopy in Patients with Intrahepatic Cholangiocarcinoma: Is It Still Useful? Visc Med 2020; 36:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber SM, Ribero D, O'Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015; 17:669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tian Y, Liu L, Yeolkar NV, et al. Diagnostic role of staging laparoscopy in a subset of biliary cancers: a meta-analysis. ANZ J Surg 2017; 87:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coelen RJ, Ruys AT, Besselink MG, et al. Diagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: a systematic review and meta-analysis. Surg Endosc 2016; 30:4163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mansour JC, Aloia TA, Crane CH, et al. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015; 17:691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coelen RJ, Ruys AT, Wiggers JK, et al. Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy. Ann Surg Oncol 2016; 23:904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thaler K, Kanneganti S, Khajanchee Y, et al. The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis. Arch Surg 2005; 140:727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grobmyer SR, Fong Y, D'Angelica M, et al. Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg 2004; 139:1326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mann CD, Neal CP, Metcalfe MS, et al. Clinical Risk Score predicts yield of staging laparoscopy in patients with colorectal liver metastases. Br J Surg 2007; 94:855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Metcalfe MS, Close JS, Iswariah H, et al. The value of laparoscopic staging for patients with colorectal metastases. Arch Surg 2003; 138:770.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weitz J, D'Angelica M, Jarnagin W, et al. Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma. Surgery 2004; 135:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoekstra LT, Bieze M, Busch OR, et al. Staging laparoscopy in patients with hepatocellular carcinoma: is it useful? Surg Endosc 2013; 27:826.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 15106 Version 21.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://www.sages.org/publications/guidelines/guidelines-for-diagnostic-laparoscopy/" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Guidelines for diagnostic laparoscopy. Reviewed and approved in April 2010. Available at: https://www.sages.org/publications/guidelines/guidelines-for-diagnostic-laparoscopy/ (Accessed on May 05, 2020).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30414682" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Minimally Invasive Staging Surgery for Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30596367" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The Value of Staging Laparoscopy for Optimal Multidisciplinary Treatment in Patients with Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23836122" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The incremental benefit of two quadrant lavage for peritoneal cytology at staging laparoscopy for oesophagogastric adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24850538" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23579506" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Laparoscopic ultrasound for hepatocellular carcinoma and colorectal liver metastasis: an overview.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20076819" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Staging laparoscopy in digestive cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19565050" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Staging laparoscopy in gastric cancer. Accuracy and impact on therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3337564" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Postoperative complications and mortality after surgery for gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3349292" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Gastric cancer: an audit of 122 consecutive cases and the results of R1 gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2458160" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Treatment of stomach cancer, a national experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24582004" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Staging laparoscopy in patients scheduled for pancreaticoduodenectomy minimizes hospitalization in the remaining life time when metastatic carcinoma is found.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25598056" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Staging laparoscopy leads to rapid induction of chemotherapy for unresectable pancreatobiliary cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12167576" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Port site metastasis after diagnostic laparoscopy for upper gastrointestinal tract malignancies: an uncommon entity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12229949" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The theories and realities of port-site metastases: a critical appraisal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15191862" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Port site metastases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15797226" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15797226" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30878666" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31749079" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35699351" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32150838" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Gastric Cancer with Radiographically Occult Metastatic Disease: Biology, Challenges, and Diagnostic Approaches.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31965376" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Four-Point Computed Tomography Scores for Evaluation of Occult Peritoneal Metastasis in Patients with Gastric Cancer: A Region-to-Region Comparison with Staging Laparoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34705049" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31549009" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Role of staging laparoscopy for gastric cancer patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33234483" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Staging laparoscopy in gastric cancer surgery. A population-based cohort study in patients undergoing gastrectomy with curative intent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34384656" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Staging laparoscopy in patients with advanced gastric cancer: A single center cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25723693" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The current role of staging laparoscopy in oesophagogastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21809111" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33949319" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : The role of laparoscopic staging for the management of gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29878364" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Repeat staging laparoscopy for gastric cancer after preoperative therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36387230" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Risk factors associated with peritoneal carcinomatosis of gastric cancer in staging laparoscopy: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21667136" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25758761" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Accuracy of staging laparoscopy in detecting peritoneal dissemination in patients with gastroesophageal adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19228527" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32066454" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35489734" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Usefulness of Surgical Staging of Gastric Cancer in Neoadjuvant Chemotherapy Candidates: A Single-center Retrospective Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17344017" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : The role of staging laparoscopy in oesophagogastric cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35058115" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : High prevalence of peritoneal metastasis in gastric cancer presenting gastric outlet obstruction: A new candidate for consecutive diagnostic staging laparoscopy and laparoscopic gastrojejunostomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30586170" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30478680" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Opportunity Lost? Diagnostic Laparoscopy in Patients with Pancreatic Cancer in the National Surgical Quality Improvement Program Database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27383694" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29649825" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : The Role of Staging Laparoscopy in Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37026837" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of More than 1,000 Consecutive Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28718038" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Reappraisal of Staging Laparoscopy for Patients with Pancreatic Adenocarcinoma: A Contemporary Analysis of 1001 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19396496" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26776846" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Indications for staging laparoscopy in pancreatic cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32897517" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Staging laparoscopy is mandatory for the treatment of pancreatic cancer to avoid missing radiologically negative metastases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35490123" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : The clinical benefits of performing staging laparoscopy for pancreatic cancer treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32722142" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : The Role of Location of Tumor in the Prognosis of the Pancreatic Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16236756" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12496532" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11992798" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : The value of laparoscopy in the management of ampullary, duodenal, and distal bile duct tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15256241" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Limitation of diagnostic laparoscopy for patients with a periampullary carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11753036" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18308214" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11986021" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16508808" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23059504" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : The role of staging laparoscopy in primary gall bladder cancer--an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26172135" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Gallbladder cancer: expert consensus statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30846038" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36641472" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : The diagnostic value of staging laparoscopy in gallbladder cancer: a nationwide cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12620915" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33442552" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Staging Laparoscopy in Patients with Intrahepatic Cholangiocarcinoma: Is It Still Useful?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26172134" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Intrahepatic cholangiocarcinoma: expert consensus statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27647697" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Diagnostic role of staging laparoscopy in a subset of biliary cancers: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26895909" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Diagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26172136" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Hilar cholangiocarcinoma: expert consensus statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27586005" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16103281" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10493478" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15611458" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17380479" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Clinical Risk Score predicts yield of staging laparoscopy in patients with colorectal liver metastases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12860759" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : The value of laparoscopic staging for patients with colorectal metastases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14976477" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23052500" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Staging laparoscopy in patients with hepatocellular carcinoma: is it useful?
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
